PROM1 and non-small cell lung carcinoma: The bioinformatics analysis from TCGA and “The HUMAN PROTEIN ATLAS” presented that CD133 was overexpressed in NSCLC clinical tissue and strongly correlated with the NSCLC “TNM” stage (Figure 2).